在子宫内膜异位症中,PGK1通过调节DDIT4核转位来调节糖解和细胞增殖
Xuemei Zhang1, Yadi Wang1, Yujie Tang1
1Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang 261000, China; School of Clinical Medicine, Shandong Second Medical University, Weifang 261000, China.
Biochimica et biophysica acta. Molecular cell research
|June 18, 2025
概括
糖酸酶1 (PGK1) 在子宫内膜异位症中升高,导致疾病的进展. 与NG52一起抑制PGK1减少了病变的生长,揭示了PGK1.
科学领域:
- 妇科 妇科 妇科 妇科
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 子宫内膜异位症 (EM) 影响到10%的生育年龄妇女.
- 脑脊髓炎的发病包括细胞增殖和代谢异常,类似于恶性瘤.
- 异常的糖解路径酶与EM发育有关.
研究的目的:
- 研究糖酸激酶1 (PGK1) 在子宫内膜异位症中的作用.
- 确定PGK1抑制是否可以治疗子宫内膜异位症.
- 在子宫内膜异位症中确定PGK1的下游标.
主要方法:
- 在子宫内膜异位症中量化PGK1水平.
- 向子宫内膜异位症小鼠模型注射PGK1抑制剂NG52.
- 评估了病变的生长,细胞迁移和增殖.
- 研究了PGK1和DNA损伤反应4 (DDIT4) 之间的关系.
主要成果:
- PGK1升高,与EM发育有很强的关联.
- 通过减少细胞迁移和增殖,NG52抑制了子宫内膜异位症病变的生长.
- 确定DDIT4是PGK1.1的新型下游目标.
- PGK1调节了DDIT4的核转位和转录活动,导致DDIT4过度表达.
结论:
- PGK1在子宫内膜异位症的发展和进展中起着至关重要的作用.
- 用NG52等抑制剂向PGK1显示出对子宫内膜异位症的治疗潜力.
- PGK1-DDIT4通路是子宫内膜异位症发病的一个关键机制.
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cell Specific Gene Expression
14.0K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.0K
IP3/DAG Signaling Pathway
12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K


